Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.
Condition: SmallpoxIntervention: Biological: IMVAMUNE (MVA-BN)Sponsors: Bavarian Nordic; National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2005 Category: Research Source Type: clinical trials
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders
Conditions: Dermatitis, Atopic; Hay FeverIntervention: Biological: IMVAMUNE (MVA-BN)Sponsors: Bavarian Nordic; National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2005 Category: Research Source Type: clinical trials
Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.
Condition: SmallpoxIntervention: Biological: IMVAMUNE (MVA-BN)Sponsors: Bavarian Nordic; National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2005 Category: Research Source Type: clinical trials
VHA Clinicians and Bioterror Events: Interactive Web-based Learning
Conditions: Smallpox; AnthraxIntervention: Behavioral: BioCASES and BioTESTSSponsors: Department of Veterans Affairs; University of Alabama at BirminghamCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2005 Category: Research Source Type: clinical trials